December 15, 2016
Pfizer/Astellas’s cancer drug study fails
Pfizer and Astellas Pharma have announced the Phase 4 PLATO study, evaluating the efficacy and safety of continued treatment with…
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
December 15, 2016
FDA nods to Pfizer’s skin disease drug
U.S. Food and Drug Administration (FDA) has approved Pfizer’s Eucrisa (crisaborole) ointment 2%, a novel non-steroidal topical phosphodieterase-4 (PDE-4) inhibitor…
December 13, 2016
Eli Lilly cuts insulin prices
Eli Lilly has announced that people who use Lilly insulin will be able to access discounted prices for their purchases…
December 13, 2016
Eli Lilly announces dividend increase
The board of directors of Eli Lilly has announced a 2 percent increase in its quarterly dividend. The dividend for…
December 13, 2016
Type 2 diabetes gets new treatment in U.S., FDA OKs Boehringer’s Synjardy XR
The U.S. Food and Drug Administration (FDA) has approved Boehringer Ingelheim’s Synjardy XR tablets for adults with type 2 diabetes.…
December 12, 2016
Achaogen passes US and European hurdles to market its plazomicin antibiotic
Achaogen’s multi-drug resistant (MDR) gram-negative product antibiotic candidate, plazomicin, met the objective for the U.S. Food and Drug Administration (FDA)…
December 12, 2016
Alvogen’s flu capsules alternative for Tamiflu
Alvogen on Monday launched the first flu capsules, generic equivalent to Roche’s Tamiflu (oseltamivir phosphate) capsules in the United States.
December 9, 2016
Alzheimer’s disease drug study disappoints Lilly
Eli Lilly has presented detailed results of its disappointing phase 3 Expedition3 trial at the 9th Clinical Trials on Alzheimer’s…
December 8, 2016
Bristol-Myers raises its quarterly dividend
Bristol-Myers Squibb Company has declared an increase of 2.6% percent in the its quarterly dividend, beginning in the first quarter…
December 8, 2016
Bayer buys BIVI’s animal health products in US
Bayer and Boehringer Ingelheim Vetmedica, Inc. (BIVI) have made a deal for Bayer to buy BIVI’s Cydectin bovine and ovine…